The article states that US Digestive Health has announced the addition of four new providers to its gastroenterology practice. The new providers will be located in the Northeast and will provide cutting-edge care and personalized treatment plans to more patients than any other provider in the region. US Digestive Health is the leading gastroenterology practice in the Northeast and one of the largest in the United States. It was formed in 2019 by Amulet Capital Partners, LP, a healthcare private equity investment firm based in Greenwich, Connecticut, in partnership with member practice partner physicians.
Author: Abhay Panchal
A new study by Harvard Medical School investigators at Massachusetts General Hospital has linked certain types of gut bacteria to the development of precancerous colon polyps. Their results are published in Cell Host & Microbe. “Researchers have done a lot of work to understand the relationship between the gut microbiome and cancer. But this new study is about understanding the microbiome’s influence on precancerous polyps,” said co-corresponding author Daniel C. Chung, HMS professor of medicine, medical co-director of the Center for Cancer Risk Assessment at Mass General Cancer Center, and a faculty member of the gastroenterology division at Mass General.
“The incidence of thrombotic events is three-fold to four-fold higher in patients with IBD compared with patients without IBD,” notes Alfred D. Nelson, MD. However, while some research from the National Inpatient Sample (NIS)—the most extensive publicly available all-payer inpatient database in the United States—has assessed this association, stratification for Crohn’s disease and ulcerative colitis in bigger studies is limited, according to the study results.
PLYMOUTH, Minn., June 6, 2023 /PRNewswire/ — GIE Medical, a clinical stage company developing solutions for patients suffering from benign stricture(s) of the esophagus or bowel, was granted designation as a Breakthrough Device from the U.S. Food and Drug Administration (FDA) for its ProTractX3™ TTS DCB indicated for dilation of recurrent benign esophageal strictures in adults with obstructive symptoms associated with narrowing of the esophagus. In December 2022, GIE Medical launched two large, multicenter randomized controlled clinical trials in the United States to investigate the company’s first of its kind multi-stage drug-coated balloon (DCB) technology, ProTractX3 TTS DCB.
Oncology is seen as an early adopter of machine learning in healthcare, and as a doctor who has been working in medical oncology for over a decade, I have seen firsthand how technology has advanced the field. Now, I work at a computer vision company that is using artificial intelligence (AI) in gastroenterology and although these areas of medicine differ, I am struck by the similarities in opportunities that technology has to help advance care and improve outcomes for patients afflicted by diseases in both fields.
CUPERTINO, CALIFORNIA Apple today announced new health features in iOS 17, iPadOS 17, and watchOS 10, expanding into two impactful areas and providing innovative tools and experiences across platforms. New mental health features allow users to log their momentary emotions and daily moods, see valuable insights, and easily access assessments and resources. iPhone, iPad, and Apple Watch offer new vision health features that encourage healthy behaviors that help reduce the risk of myopia, and the Health app comes to iPad, giving users new ways to see their health data. All of these new features — and existing health features —…
With pandemic protections guaranteeing Medicaid coverage now gone, many states have begun unenrolling certain individuals — a process that could lead around 15 million people to lose coverage over the next year. A deep dive into the end of the COVID PHE Millions of Americans could lose Medicaid coverageIn 2020, states that received enhanced Medicaid funding were prohibited from dropping individuals from the program during the COVID-19 public health emergency. During the pandemic, Medicaid enrollment increased significantly, and over 91 million people were enrolled in either Medicaid or CHIP as of October. However, the continuous coverage requirement recently ended on…
In March, insurer UnitedHealthcare announced changes to prior authorization for certain GI procedures. The night before changes were to take effect on June 1, UHC reversed the plan, opting instead for an advanced notification alternative. The new plan requires gastroenterologists to submit certain patient data, which it will collect for future use in a “gold card” program, set to launch in 2024. Gastroenterologist Linda Lee, MD, medical director of endoscopy at Boston-based Brigham and Women’s Hospital and associate professor of medicine at Boston’s Harvard Medical School, says that gastroenterologists should be leery of UHC’s prior authorization alternative.
G&H How common are endoscopic recurrence and clinical recurrence of Crohn’s disease following surgery? MR The simple answer is that both are common. Endoscopic recurrence refers to the appearance of ulcerations or inflammation representing Crohn’s disease on colonoscopy, usually within the first year after surgical treatment. Historically, in patients with Crohn’s disease who have been treated with surgery and have not started a postoperative medication, endoscopic recurrence has been reported in up to 90%, which is quite high. Clinical recurrence, on the other hand, involves the return of symptoms that represent active Crohn’s disease, and often a complication such as…
The gut microbiome, or the colony of bacteria living inside our colon, might be an important key to help determine whether a young person will develop colon cancer, a new study suggests. Scientists have known certain bacteria can disturb the lining of the colon, which may result in the formation of tumors and the development of cancer. Building upon this, researchers at Georgetown University set out to find which bacteria strains are more present in the guts of young people who develop colon cancer.